Live and Inactivated Chlamydia trachomatis Mouse Pneumonitis Strain Induces the Maturation of Dendritic Cells That Are Phenotypically and Immunologically Distinct
The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to develop following natural chlamydial infection in humans, early vaccine trials using heat-killed C. trachomatis resulted in limited and tran...
Saved in:
Published in | Infection and Immunity Vol. 73; no. 3; pp. 1568 - 1577 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Society for Microbiology
01.03.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to develop following natural chlamydial infection in humans, early vaccine trials using heat-killed C. trachomatis resulted in limited and transient protection with possible enhanced disease during follow-up. Thus, immunity following natural infection with live chlamydia may differ from immune responses induced by immunization with inactivated chlamydia. To study this differing immunology, we used murine bone marrow-derived dendritic cells (DC) to examine DC maturation and immune effector function induced by live and UV-irradiated C. trachomatis elementary bodies (live EBs and UV-EB, respectively). DC exposed to live EBs acquired a mature DC morphology; expressed high levels of major histocompatibility complex (MHC) class II, CD80, CD86, CD40, and ICAM-1; produced elevated amounts of interleukin-12 and tumor necrosis factor alpha; and were efficiently recognized by Chlamydia-specific CD4⁺ T cells. In contrast, UV-EB-pulsed DC expressed low levels of CD40 and CD86 but displayed high levels of MHC class II, ICAM-1, and CD80; secreted low levels of proinflammatory cytokines; and exhibited reduced recognition by Chlamydia-specific CD4⁺ T cells. Adoptive transfer of live EB-pulsed DC was more effective than that of UV-EB-pulsed DC at protecting mice against challenge with live C. trachomatis. The expression of DC maturation markers and immune protection induced by UV-EB could be significantly enhanced by costimulation of DC ex vivo with UV-EB and oligodeoxynucleotides containing cytosine phosphate guanosine; however, the level of protection was significantly less than that achieved by using DC pulsed ex vivo with viable EBs. Thus, exposure of DC to live EBs results in a mature DC phenotype which is able to promote protective immunity, while exposure to UV-EB generates a semimature DC phenotype with less protective potential. This result may explain in part the differences in protective immunity induced by natural infection and immunization with whole inactivated organisms and is relevant to rational chlamydia vaccine design strategies. |
---|---|
AbstractList | The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to develop following natural chlamydial infection in humans, early vaccine trials using heat-killed C. trachomatis resulted in limited and transient protection with possible enhanced disease during follow-up. Thus, immunity following natural infection with live chlamydia may differ from immune responses induced by immunization with inactivated chlamydia. To study this differing immunology, we used murine bone marrow-derived dendritic cells (DC) to examine DC maturation and immune effector function induced by live and UV-irradiated C. trachomatis elementary bodies (live EBs and UV-EB, respectively). DC exposed to live EBs acquired a mature DC morphology; expressed high levels of major histocompatibility complex (MHC) class II, CD80, CD86, CD40, and ICAM-1; produced elevated amounts of interleukin-12 and tumor necrosis factor alpha; and were efficiently recognized by Chlamydia-specific CD4⁺ T cells. In contrast, UV-EB-pulsed DC expressed low levels of CD40 and CD86 but displayed high levels of MHC class II, ICAM-1, and CD80; secreted low levels of proinflammatory cytokines; and exhibited reduced recognition by Chlamydia-specific CD4⁺ T cells. Adoptive transfer of live EB-pulsed DC was more effective than that of UV-EB-pulsed DC at protecting mice against challenge with live C. trachomatis. The expression of DC maturation markers and immune protection induced by UV-EB could be significantly enhanced by costimulation of DC ex vivo with UV-EB and oligodeoxynucleotides containing cytosine phosphate guanosine; however, the level of protection was significantly less than that achieved by using DC pulsed ex vivo with viable EBs. Thus, exposure of DC to live EBs results in a mature DC phenotype which is able to promote protective immunity, while exposure to UV-EB generates a semimature DC phenotype with less protective potential. This result may explain in part the differences in protective immunity induced by natural infection and immunization with whole inactivated organisms and is relevant to rational chlamydia vaccine design strategies. The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to develop following natural chlamydial infection in humans, early vaccine trials using heat-killed C. trachomatis resulted in limited and transient protection with possible enhanced disease during follow-up. Thus, immunity following natural infection with live chlamydia may differ from immune responses induced by immunization with inactivated chlamydia. To study this differing immunology, we used murine bone marrow-derived dendritic cells (DC) to examine DC maturation and immune effector function induced by live and UV-irradiated C. trachomatis elementary bodies (live EBs and UV-EB, respectively). DC exposed to live EBs acquired a mature DC morphology; expressed high levels of major histocompatibility complex (MHC) class II, CD80, CD86, CD40, and ICAM-1; produced elevated amounts of interleukin-12 and tumor necrosis factor alpha; and were efficiently recognized by Chlamydia-specific CD4+ T cells. In contrast, UV-EB-pulsed DC expressed low levels of CD40 and CD86 but displayed high levels of MHC class II, ICAM-1, and CD80; secreted low levels of proinflammatory cytokines; and exhibited reduced recognition by Chlamydia-specific CD4+ T cells. Adoptive transfer of live EB-pulsed DC was more effective than that of UV-EB-pulsed DC at protecting mice against challenge with live C. trachomatis. The expression of DC maturation markers and immune protection induced by UV-EB could be significantly enhanced by costimulation of DC ex vivo with UV-EB and oligodeoxynucleotides containing cytosine phosphate guanosine; however, the level of protection was significantly less than that achieved by using DC pulsed ex vivo with viable EBs. Thus, exposure of DC to live EBs results in a mature DC phenotype which is able to promote protective immunity, while exposure to UV-EB generates a semimature DC phenotype with less protective potential. This result may explain in part the differences in protective immunity induced by natural infection and immunization with whole inactivated organisms and is relevant to rational chlamydia vaccine design strategies. Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue IAI About IAI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy Connect to IAI IAI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0019-9567 Online ISSN: 1098-5522 Copyright © 2014 by the American Society for Microbiology. For an alternate route to IAI .asm.org, visit: IAI The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to develop following natural chlamydial infection in humans, early vaccine trials using heat-killed C. trachomatis resulted in limited and transient protection with possible enhanced disease during follow-up. Thus, immunity following natural infection with live chlamydia may differ from immune responses induced by immunization with inactivated chlamydia. To study this differing immunology, we used murine bone marrow-derived dendritic cells (DC) to examine DC maturation and immune effector function induced by live and UV-irradiated C. trachomatis elementary bodies (live EBs and UV-EB, respectively). DC exposed to live EBs acquired a mature DC morphology; expressed high levels of major histocompatibility complex (MHC) class II, CD80, CD86, CD40, and ICAM-1; produced elevated amounts of interleukin-12 and tumor necrosis factor alpha; and were efficiently recognized by Chlamydia-specific CD4 super(+) T cells. In contrast, UV-EB-pulsed DC expressed low levels of CD40 and CD86 but displayed high levels of MHC class II, ICAM-1, and CD80; secreted low levels of proinflammatory cytokines; and exhibited reduced recognition by Chlamydia-specific CD4 super(+) T cells. Adoptive transfer of live EB-pulsed DC was more effective than that of UV-EB-pulsed DC at protecting mice against challenge with live C. trachomatis. The expression of DC maturation markers and immune protection induced by UV-EB could be significantly enhanced by costimulation of DC ex vivo with UV-EB and oligodeoxynucleotides containing cytosine phosphate guanosine; however, the level of protection was significantly less than that achieved by using DC pulsed ex vivo with viable EBs. Thus, exposure of DC to live EBs results in a mature DC phenotype which is able to promote protective immunity, while exposure to UV-EB generates a semimature DC phenotype with less protective potential. This result may explain in part the differences in protective immunity induced by natural infection and immunization with whole inactivated organisms and is relevant to rational chlamydia vaccine design strategies. ABSTRACT The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to develop following natural chlamydial infection in humans, early vaccine trials using heat-killed C. trachomatis resulted in limited and transient protection with possible enhanced disease during follow-up. Thus, immunity following natural infection with live chlamydia may differ from immune responses induced by immunization with inactivated chlamydia. To study this differing immunology, we used murine bone marrow-derived dendritic cells (DC) to examine DC maturation and immune effector function induced by live and UV-irradiated C. trachomatis elementary bodies (live EBs and UV-EB, respectively). DC exposed to live EBs acquired a mature DC morphology; expressed high levels of major histocompatibility complex (MHC) class II, CD80, CD86, CD40, and ICAM-1; produced elevated amounts of interleukin-12 and tumor necrosis factor alpha; and were efficiently recognized by Chlamydia -specific CD4 + T cells. In contrast, UV-EB-pulsed DC expressed low levels of CD40 and CD86 but displayed high levels of MHC class II, ICAM-1, and CD80; secreted low levels of proinflammatory cytokines; and exhibited reduced recognition by Chlamydia- specific CD4 + T cells. Adoptive transfer of live EB-pulsed DC was more effective than that of UV-EB-pulsed DC at protecting mice against challenge with live C. trachomatis . The expression of DC maturation markers and immune protection induced by UV-EB could be significantly enhanced by costimulation of DC ex vivo with UV-EB and oligodeoxynucleotides containing cytosine phosphate guanosine; however, the level of protection was significantly less than that achieved by using DC pulsed ex vivo with viable EBs. Thus, exposure of DC to live EBs results in a mature DC phenotype which is able to promote protective immunity, while exposure to UV-EB generates a semimature DC phenotype with less protective potential. This result may explain in part the differences in protective immunity induced by natural infection and immunization with whole inactivated organisms and is relevant to rational chlamydia vaccine design strategies. The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to develop following natural chlamydial infection in humans, early vaccine trials using heat-killed C. trachomatis resulted in limited and transient protection with possible enhanced disease during follow-up. Thus, immunity following natural infection with live chlamydia may differ from immune responses induced by immunization with inactivated chlamydia. To study this differing immunology, we used murine bone marrow-derived dendritic cells (DC) to examine DC maturation and immune effector function induced by live and UV-irradiated C. trachomatis elementary bodies (live EBs and UV-EB, respectively). DC exposed to live EBs acquired a mature DC morphology; expressed high levels of major histocompatibility complex (MHC) class II, CD80, CD86, CD40, and ICAM-1; produced elevated amounts of interleukin-12 and tumor necrosis factor alpha; and were efficiently recognized by Chlamydia -specific CD4 + T cells. In contrast, UV-EB-pulsed DC expressed low levels of CD40 and CD86 but displayed high levels of MHC class II, ICAM-1, and CD80; secreted low levels of proinflammatory cytokines; and exhibited reduced recognition by Chlamydia- specific CD4 + T cells. Adoptive transfer of live EB-pulsed DC was more effective than that of UV-EB-pulsed DC at protecting mice against challenge with live C. trachomatis . The expression of DC maturation markers and immune protection induced by UV-EB could be significantly enhanced by costimulation of DC ex vivo with UV-EB and oligodeoxynucleotides containing cytosine phosphate guanosine; however, the level of protection was significantly less than that achieved by using DC pulsed ex vivo with viable EBs. Thus, exposure of DC to live EBs results in a mature DC phenotype which is able to promote protective immunity, while exposure to UV-EB generates a semimature DC phenotype with less protective potential. This result may explain in part the differences in protective immunity induced by natural infection and immunization with whole inactivated organisms and is relevant to rational chlamydia vaccine design strategies. |
Author | Rey-Ladino, Jose Zaharik, Michelle L Brunham, Robert C Shen, Caixia Koochesfahani, Kasra M |
AuthorAffiliation | University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada 1 |
AuthorAffiliation_xml | – name: University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada 1 |
Author_xml | – sequence: 1 fullname: Rey-Ladino, Jose – sequence: 2 fullname: Koochesfahani, Kasra M – sequence: 3 fullname: Zaharik, Michelle L – sequence: 4 fullname: Shen, Caixia – sequence: 5 fullname: Brunham, Robert C |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16723695$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15731055$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkk1v1DAQhiNURLeFv0DNodyy-DN2LkirLR8rbQVS27PlOM7GKLEX2ynav8MvxausWjhxsjzzzOuZ8XtRnDnvTFFcIbhECIsPm9VmycmSLBGrRIkY50sMIXtRLBCsRckYxmfFAkJUlzWr-HlxEeOPfKWUilfFeS4gCDK2KH5v7aMByrVg45RO9lEl04J1P6jx0FoFUlC696NKNoJbP0UDvjszjd7ZY-Qup63Lpe2kTQSpN-BWpSlk3DvgO3BjXBsyqsHaDEME971KYBWySm-cT4e91WoYDnMD4zg5P_jdKXZjY7JOp9fFy04N0bw5nZfFw-dP9-uv5fbbl816tS015TyVFeSNaGpBYE07glrKiWjyjAQTzjTVFDPCWC0qgTXuUIeqtmsaIRrGWwxbTS6Lj7PufmpG02rj8nSD3Ac7qnCQXln5b8bZXu78o0SwojUlWeD9SSD4n5OJSY426jy3ciavTlacVriq2X9BxAVCFaYZ5DOog48xmO6pGwTl0QgyG0FyIok8GkEejSCPRsiVb_8e5rnu9PMZuD4BKuZ9d0E5beMzV3FM5l7fzVxvd_0vG4xUcZQ2L-Pp2cxczUynvFS7kHUe7nB229FxCGNC_gAzFNWK |
CODEN | INFIBR |
CitedBy_id | crossref_primary_10_1038_icb_2015_79 crossref_primary_10_1111_j_1574_695X_2010_00653_x crossref_primary_10_1016_j_vaccine_2011_07_012 crossref_primary_10_1016_j_ajpath_2010_11_019 crossref_primary_10_1111_j_1574_695X_2008_00523_x crossref_primary_10_1111_j_1365_2567_2007_02642_x crossref_primary_10_1038_srep37723 crossref_primary_10_1128_IAI_73_11_7170_7179_2005 crossref_primary_10_1186_s12865_017_0212_1 crossref_primary_10_3390_microorganisms11030604 crossref_primary_10_1016_j_vaccine_2011_10_059 crossref_primary_10_2166_wh_2020_040 crossref_primary_10_3390_ani13020252 crossref_primary_10_1016_j_ejps_2020_105651 crossref_primary_10_1128_IAI_01584_07 crossref_primary_10_1111_j_1574_695X_2010_00729_x crossref_primary_10_1164_rccm_200804_517OC crossref_primary_10_4049_jimmunol_1002952 crossref_primary_10_1111_j_1462_5822_2007_01001_x crossref_primary_10_1038_icb_2015_20 crossref_primary_10_1038_mi_2008_57 crossref_primary_10_4049_jimmunol_177_1_459 crossref_primary_10_1111_j_1365_2567_2006_02488_x crossref_primary_10_1111_j_1574_695X_2007_00367_x crossref_primary_10_1371_journal_pone_0059958 crossref_primary_10_1530_REP_16_0561 crossref_primary_10_4049_jimmunol_1002519 crossref_primary_10_1016_S1001_9294_09_60043_2 crossref_primary_10_1586_eog_11_12 crossref_primary_10_1016_j_vaccine_2012_12_057 crossref_primary_10_4049_jimmunol_180_4_2459 crossref_primary_10_4161_hv_6_8_12299 crossref_primary_10_1089_acm_2006_12_409 crossref_primary_10_1128_IAI_01618_06 crossref_primary_10_1016_j_vaccine_2006_12_019 crossref_primary_10_1128_CMR_00105_13 crossref_primary_10_1038_mi_2007_19 crossref_primary_10_1128_AAC_01826_20 |
Cites_doi | 10.1002/elps.1150180338 10.1084/jem.185.2.317 10.1146/annurev.immunol.21.120601.141040 10.1084/jem.176.6.1693 10.4049/jimmunol.160.3.1297 10.4049/jimmunol.161.3.1439 10.4049/jimmunol.169.11.6324 10.4269/ajtmh.1990.42.358 10.1038/nri1001 10.1084/jem.161.3.526 10.1128/IAI.69.7.4667-4672.2001 10.1172/JCI0215962 10.1084/jem.20020147 10.4049/jimmunol.173.3.1934 10.1007/BF03401798 10.4049/jimmunol.164.8.4212 10.1084/jem.172.2.631 10.1002/eji.200324387 10.4049/jimmunol.172.10.6281 10.1128/IAI.70.6.2741-2751.2002 10.4049/jimmunol.172.4.2407 10.4049/jimmunol.168.11.5589 10.1086/315630 10.1016/S0092-8674(01)00456-1 10.1084/jem.20040317 10.1046/j.1365-2958.2003.03462.x 10.1046/j.1462-5822.2003.00291.x 10.1128/IAI.68.12.6979-6987.2000 10.1128/iai.65.8.3386-3390.1997 10.4049/jimmunol.167.6.3316 10.1084/jem.193.2.233 10.2165/00063030-200216010-00003 10.1128/iai.64.4.1208-1214.1996 10.4049/jimmunol.172.3.1727 10.1073/pnas.1331135100 10.1016/S1471-4906(02)02281-0 10.1038/4000 10.1128/IAI.70.7.3793-3803.2002 10.1002/1521-4141(200203)32:3<742::AID-IMMU742>3.0.CO;2-9 10.1038/nri1256 10.1097/00007435-197804000-00011 10.1093/infdis/173.4.950 10.1084/jem.188.5.809 10.1016/0002-9394(79)90076-X 10.1016/S1074-7613(03)00140-7 10.1128/IAI.67.4.1763-1769.1999 10.1093/clinids/7.6.717 10.1038/32588 10.1128/IAI.71.1.117-125.2003 10.1084/jem.189.12.1931 10.1016/j.it.2004.04.006 10.1084/jem.191.9.1525 10.1128/IAI.70.3.1097-1105.2002 10.1002/jlb.66.3.462 |
ContentType | Journal Article |
Copyright | 2005 INIST-CNRS Copyright © 2005, American Society for Microbiology 2005 |
Copyright_xml | – notice: 2005 INIST-CNRS – notice: Copyright © 2005, American Society for Microbiology 2005 |
DBID | FBQ IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7T5 C1K H94 7X8 5PM |
DOI | 10.1128/IAI.73.3.1568-1577.2005 |
DatabaseName | AGRIS Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Immunology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1098-5522 |
EndPage | 1577 |
ExternalDocumentID | 10_1128_IAI_73_3_1568_1577_2005 15731055 16723695 iai_73_3_1568 US201400141223 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 18M 29I 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 85S ABOCM ACGFO ADBBV AENEX AFMIJ AGCDD AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CS3 D0S DIK DU5 E3Z EBS EJD F5P FBQ FRP GX1 HYE HZ~ H~9 IH2 J5H KQ8 L7B MVM NEJ O9- OHT OK1 P2P RHF RHI RNS RPM RSF SJN TR2 TWZ UCJ UPT VH1 VQA W2D W8F WH7 WHG WOQ X7M XFK Y6R ZA5 ZGI ZXP ~KM 08R AAPBV AAUGY H13 IQODW CGR CUY CVF ECM EIF NPM AAYXX AGVNZ CITATION 7QL 7T5 C1K H94 7X8 5PM |
ID | FETCH-LOGICAL-c477t-607b8b983094f31d4738b05532375c4c42535598682c2f1f16dfbb88b57d20dc3 |
IEDL.DBID | RPM |
ISSN | 0019-9567 |
IngestDate | Tue Sep 17 21:13:05 EDT 2024 Fri Aug 16 01:02:34 EDT 2024 Tue Aug 27 04:30:18 EDT 2024 Thu Sep 12 18:18:50 EDT 2024 Thu May 23 23:08:23 EDT 2024 Sun Oct 22 16:06:11 EDT 2023 Wed May 18 15:26:55 EDT 2016 Wed Dec 27 19:17:30 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Lung disease Dendritic cell Pneumonia Chlamydiaceae Microbiology Respiratory disease Rodentia Chlamydia trachomatis Immunity Vertebrata Mammalia Mouse Chlamydiales Bacteria Inactivated strain |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c477t-607b8b983094f31d4738b05532375c4c42535598682c2f1f16dfbb88b57d20dc3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Editor: J. L. Flynn Corresponding author. Mailing address: University of British Columbia Centre for Disease Control, 655 West 12th Ave., Vancouver, BC V5Z 4R4, Canada. Phone: (604) 660-2626. Fax: (604) 660-6066. E-mail: robert.brunham@bccdc.ca. |
PMID | 15731055 |
PQID | 17811624 |
PQPubID | 23462 |
PageCount | 10 |
ParticipantIDs | crossref_primary_10_1128_IAI_73_3_1568_1577_2005 fao_agris_US201400141223 pascalfrancis_primary_16723695 pubmed_primary_15731055 proquest_miscellaneous_67462695 pubmedcentral_primary_oai_pubmedcentral_nih_gov_1064943 proquest_miscellaneous_17811624 highwire_asm_iai_73_3_1568 |
PublicationCentury | 2000 |
PublicationDate | 2005-03-01 |
PublicationDateYYYYMMDD | 2005-03-01 |
PublicationDate_xml | – month: 03 year: 2005 text: 2005-03-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Infection and Immunity |
PublicationTitleAlternate | Infect Immun |
PublicationYear | 2005 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | 8606080 - Infect Immun. 1996 Apr;64(4):1208-14 11036772 - Curr Top Microbiol Immunol. 2000;251:167-71 12200066 - Trends Immunol. 2002 Sep;23(9):445-9 11854188 - Infect Immun. 2002 Mar;70(3):1097-105 9234802 - Infect Immun. 1997 Aug;65(8):3386-90 12818162 - Immunity. 2003 Jun;18(6):813-23 11908999 - BioDrugs. 2002;16(1):19-35 9730883 - J Exp Med. 1998 Sep 7;188(5):809-18 9846579 - Nat Med. 1998 Dec;4(12):1409-15 2373994 - J Exp Med. 1990 Aug 1;172(2):631-40 10328037 - Sex Transm Dis. 1978 Apr-Jun;5(2):73-7 2331044 - Am J Trop Med Hyg. 1990 Apr;42(4):358-64 11083822 - Infect Immun. 2000 Dec;68(12):6979-87 9016880 - J Exp Med. 1997 Jan 20;185(2):317-28 1460426 - J Exp Med. 1992 Dec 1;176(6):1693-702 9521319 - Nature. 1998 Mar 19;392(6673):245-52 3871837 - J Exp Med. 1985 Mar 1;161(3):526-46 9150942 - Electrophoresis. 1997 Mar-Apr;18(3-4):563-7 10997341 - Mol Med. 2000 Jul;6(7):604-12 12070284 - J Exp Med. 2002 Jun 17;195(12):1565-73 12444139 - J Immunol. 2002 Dec 1;169(11):6324-31 15207502 - Trends Immunol. 2004 Jul;25(7):353-9 12615891 - Annu Rev Immunol. 2003;21:685-711 10790427 - J Exp Med. 2000 May 1;191(9):1525-34 14704765 - Nat Rev Immunol. 2004 Jan;4(1):24-34 11544320 - J Immunol. 2001 Sep 15;167(6):3316-23 10754317 - J Immunol. 2000 Apr 15;164(8):4212-9 11208863 - J Exp Med. 2001 Jan 15;193(2):233-8 15265927 - J Immunol. 2004 Aug 1;173(3):1934-40 11402013 - Infect Immun. 2001 Jul;69(7):4667-72 12010958 - Infect Immun. 2002 Jun;70(6):2741-51 12023355 - J Immunol. 2002 Jun 1;168(11):5589-95 11509173 - Cell. 2001 Aug 10;106(3):259-62 12694613 - Mol Microbiol. 2003 May;48(3):671-83 434096 - Am J Ophthalmol. 1979 Mar;87(3):350-3 15128817 - J Immunol. 2004 May 15;172(10):6281-9 12496156 - Infect Immun. 2003 Jan;71(1):117-25 11870618 - Eur J Immunol. 2002 Mar;32(3):742-51 14764711 - J Immunol. 2004 Feb 15;172(4):2407-15 10839755 - J Infect Dis. 2000 Jun;181 Suppl 3:S538-43 12563297 - Nat Rev Immunol. 2003 Feb;3(2):133-46 12070296 - J Clin Invest. 2002 Jun;109(12):1519-26 10085016 - Infect Immun. 1999 Apr;67(4):1763-9 14734755 - J Immunol. 2004 Feb 1;172(3):1727-34 8603976 - J Infect Dis. 1996 Apr;173(4):950-6 10496317 - J Leukoc Biol. 1999 Sep;66(3):462-70 12864809 - Cell Microbiol. 2003 Aug;5(8):493-500 15197224 - J Exp Med. 2004 Jun 21;199(12):1607-18 4070905 - Rev Infect Dis. 1985 Nov-Dec;7(6):717-25 12065523 - Infect Immun. 2002 Jul;70(7):3793-803 9570547 - J Immunol. 1998 Feb 1;160(3):1297-303 9686609 - J Immunol. 1998 Aug 1;161(3):1439-46 10377188 - J Exp Med. 1999 Jun 21;189(12):1931-8 12234994 - Cancer Res. 2002 Sep 15;62(18):5260-6 15048708 - Eur J Immunol. 2004 Apr;34(4):981-9 12815105 - Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8478-83 e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_28_2 e_1_3_2_41_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_22_2 e_1_3_2_45_2 (e_1_3_2_35_2) 1998; 160 e_1_3_2_24_2 e_1_3_2_47_2 (e_1_3_2_40_2) 2000; 251 e_1_3_2_9_2 e_1_3_2_16_2 (e_1_3_2_30_2) 2002; 62 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_58_2 e_1_3_2_3_2 e_1_3_2_14_2 (e_1_3_2_56_2) 1998; 161 e_1_3_2_50_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_53_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_2_2 |
References_xml | – ident: e_1_3_2_4_2 doi: 10.1002/elps.1150180338 – ident: e_1_3_2_54_2 doi: 10.1084/jem.185.2.317 – ident: e_1_3_2_47_2 doi: 10.1146/annurev.immunol.21.120601.141040 – ident: e_1_3_2_20_2 doi: 10.1084/jem.176.6.1693 – volume: 160 start-page: 1297 year: 1998 ident: e_1_3_2_35_2 publication-title: J. Immunol. doi: 10.4049/jimmunol.160.3.1297 – volume: 161 start-page: 1439 year: 1998 ident: e_1_3_2_56_2 publication-title: J. Immunol. doi: 10.4049/jimmunol.161.3.1439 – ident: e_1_3_2_24_2 doi: 10.4049/jimmunol.169.11.6324 – ident: e_1_3_2_51_2 doi: 10.4269/ajtmh.1990.42.358 – ident: e_1_3_2_53_2 doi: 10.1038/nri1001 – ident: e_1_3_2_43_2 doi: 10.1084/jem.161.3.526 – ident: e_1_3_2_45_2 doi: 10.1128/IAI.69.7.4667-4672.2001 – ident: e_1_3_2_48_2 doi: 10.1172/JCI0215962 – ident: e_1_3_2_38_2 doi: 10.1084/jem.20020147 – ident: e_1_3_2_46_2 doi: 10.4049/jimmunol.173.3.1934 – ident: e_1_3_2_25_2 doi: 10.1007/BF03401798 – ident: e_1_3_2_18_2 doi: 10.4049/jimmunol.164.8.4212 – ident: e_1_3_2_21_2 doi: 10.1084/jem.172.2.631 – ident: e_1_3_2_17_2 doi: 10.1002/eji.200324387 – ident: e_1_3_2_37_2 doi: 10.4049/jimmunol.172.10.6281 – ident: e_1_3_2_32_2 doi: 10.1128/IAI.70.6.2741-2751.2002 – ident: e_1_3_2_39_2 doi: 10.4049/jimmunol.172.4.2407 – ident: e_1_3_2_10_2 doi: 10.4049/jimmunol.168.11.5589 – ident: e_1_3_2_6_2 doi: 10.1086/315630 – ident: e_1_3_2_23_2 doi: 10.1016/S0092-8674(01)00456-1 – ident: e_1_3_2_55_2 – ident: e_1_3_2_12_2 doi: 10.1084/jem.20040317 – ident: e_1_3_2_11_2 doi: 10.1046/j.1365-2958.2003.03462.x – ident: e_1_3_2_31_2 doi: 10.1046/j.1462-5822.2003.00291.x – ident: e_1_3_2_33_2 doi: 10.1128/IAI.68.12.6979-6987.2000 – ident: e_1_3_2_29_2 doi: 10.1128/iai.65.8.3386-3390.1997 – ident: e_1_3_2_36_2 doi: 10.4049/jimmunol.167.6.3316 – ident: e_1_3_2_9_2 doi: 10.1084/jem.193.2.233 – volume: 251 start-page: 167 year: 2000 ident: e_1_3_2_40_2 publication-title: Curr. Top. Microbiol. Immunol. – ident: e_1_3_2_19_2 doi: 10.2165/00063030-200216010-00003 – ident: e_1_3_2_42_2 doi: 10.1128/iai.64.4.1208-1214.1996 – ident: e_1_3_2_22_2 doi: 10.4049/jimmunol.172.3.1727 – ident: e_1_3_2_3_2 doi: 10.1073/pnas.1331135100 – ident: e_1_3_2_27_2 doi: 10.1016/S1471-4906(02)02281-0 – ident: e_1_3_2_15_2 doi: 10.1038/4000 – ident: e_1_3_2_7_2 doi: 10.1128/IAI.70.7.3793-3803.2002 – ident: e_1_3_2_28_2 doi: 10.1002/1521-4141(200203)32:3<742::AID-IMMU742>3.0.CO;2-9 – ident: e_1_3_2_16_2 doi: 10.1038/nri1256 – ident: e_1_3_2_13_2 doi: 10.1097/00007435-197804000-00011 – ident: e_1_3_2_5_2 doi: 10.1093/infdis/173.4.950 – ident: e_1_3_2_50_2 doi: 10.1084/jem.188.5.809 – ident: e_1_3_2_8_2 doi: 10.1016/0002-9394(79)90076-X – ident: e_1_3_2_34_2 doi: 10.1016/S1074-7613(03)00140-7 – ident: e_1_3_2_26_2 doi: 10.1128/IAI.67.4.1763-1769.1999 – ident: e_1_3_2_14_2 doi: 10.1093/clinids/7.6.717 – ident: e_1_3_2_2_2 doi: 10.1038/32588 – ident: e_1_3_2_41_2 doi: 10.1128/IAI.71.1.117-125.2003 – ident: e_1_3_2_57_2 doi: 10.1084/jem.189.12.1931 – ident: e_1_3_2_52_2 doi: 10.1016/j.it.2004.04.006 – ident: e_1_3_2_58_2 doi: 10.1084/jem.191.9.1525 – volume: 62 start-page: 5260 year: 2002 ident: e_1_3_2_30_2 publication-title: Cancer Res. – ident: e_1_3_2_44_2 doi: 10.1128/IAI.70.3.1097-1105.2002 – ident: e_1_3_2_49_2 doi: 10.1002/jlb.66.3.462 |
SSID | ssj0014448 |
Score | 2.0464518 |
Snippet | The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to... Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... ABSTRACT The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does... The intracellular bacterial pathogen Chlamydia trachomatis is a major cause of sexually transmitted disease worldwide. While protective immunity does appear to... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis highwire fao |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1568 |
SubjectTerms | Adoptive Transfer Animals Bacterial Vaccines - administration & dosage Bacterial Vaccines - immunology Bacteriology Biological and medical sciences Bone Marrow Cells Cell Differentiation - immunology Chlamydia Infections - immunology Chlamydia Infections - microbiology Chlamydia Infections - prevention & control Chlamydia trachomatis Chlamydia trachomatis - growth & development Chlamydia trachomatis - immunology Chlamydia trachomatis - pathogenicity Chlamydia trachomatis - radiation effects cytosine dendritic cells Dendritic Cells - cytology Dendritic Cells - immunology Dendritic Cells - metabolism Female Fundamental and applied biological sciences. Psychology guanosine Histocompatibility Antigens Class II - metabolism Host Response and Inflammation humans immune response immunization Intercellular Adhesion Molecule-1 - metabolism interleukin-12 major histocompatibility complex Mice Mice, Inbred BALB C Mice, Inbred C57BL Microbiology Miscellaneous oligodeoxyribonucleotides pathogens Phenotype pneumonia Pneumonia, Bacterial - immunology Pneumonia, Bacterial - microbiology Pneumonia, Bacterial - prevention & control T-lymphocytes tumor necrosis factor-alpha ultraviolet radiation Ultraviolet Rays vaccine development Vaccines, Inactivated - administration & dosage Vaccines, Inactivated - immunology |
Title | Live and Inactivated Chlamydia trachomatis Mouse Pneumonitis Strain Induces the Maturation of Dendritic Cells That Are Phenotypically and Immunologically Distinct |
URI | http://iai.asm.org/content/73/3/1568.abstract https://www.ncbi.nlm.nih.gov/pubmed/15731055 https://search.proquest.com/docview/17811624 https://search.proquest.com/docview/67462695 https://pubmed.ncbi.nlm.nih.gov/PMC1064943 |
Volume | 73 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBaaAht2GbbuUXdbp8OuzsOSJfsYpCuaYR4KtAF6EyRbXgIkctA4A_J_-kNLyvbSDNtlVz8oWaT4sEh-hHxJUrAJzMZhXloR8ohrbHmbhqlhuhAGDLbBQuHsh7ia8W938d0RibtaGJ-0n5tF3y1XfbeY-9zK9SofdHlig-tsAmEMTzkb9EhPMtaF6O3RAee8Vb8wYixkm9QFengwHU_7kvVZH4IWiJ1iKf1PFQ_NIxlCRR5Yp16pqyd9gzFtUm9g5coG8uJvPumfqZVPbNXlK_KydTLpuPmY1-TIuhPyrIGd3J2Q51l7oP6GPIzpd9B3VLuCTh0WOfwC57OgkzlIyg5khwJ9xFPBIgiaVduNpdfObleoCuDKjYeYoAgAAgqHgjdJM2wV6vlNq5JeWFd4NAU6scvlht7OdQ0TAypz66p6t0YhWe6aCWCtSqeM4doF6h-X12_J7PLr7eQqbIEbwpxLWYdiKE1i0oRB7FiyUcElSwysLouYjHOeg55gvjF8EuVROSpHoiiNSRITyyIaFjl7R45d5ewpoUxIcNlihC0DO2pHxjL8aWmE0ZbnwzQgw45hat3051A-rokSBexWkimmkN0K2Y2gm3FAToGxSv8ELapmNxHGmJjuCo5SQM46biu9WamFXuwpBOT8gP_78WCOTKRA-HMnEAo2KZ68aGeBM2qE9bwi4v9-QkgOoSXSeN8I0J56K5oBkQei9fsBbBB-eAf2jW8U3u6Ts_9-8wN54VvV-py7j-S4vt_aT-CE1ebcb7pH-C8twg |
link.rule.ids | 230,315,733,786,790,891,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECWSFF0uXdIlTtuEh14l2yIlSkfDaWC3VhAgTpEbQUpUbNSmjVou4H5PP7QzlFTHQXtor1pGlPQ4Czkzj5APcQI2gZnQywoTeTzgClveJl6imcojDQZbY6FwehENrvmnm_Bmj4RNLYxL2s_01LezuW-nE5dbuZxn7SZPrH2Z9iGM4Qln7X3yAOZrIJogvd484JzXChieGUaiTusCTdwe9oa-YD7zIWyB6CkUwi2rOHIewZAscsc-7RdqcadzMCZOqhV8u6IivfiTV3o_ufKOtTp_Rr4071klqXz116X2sx_3WkD-84d4Tp7W_ivtVadfkD1jD8nDitFyc0gepfVe_Uvys0dHoEqpsjkdWqyf-A5-bU77EwDhBmBJYeBI1YL1FTRdrFeGXlqznqOWgSNXjr2CIrcI6DIKjipNsQupgxJdFPTM2NwRNdC-mc1WdDxRJQwMpEyMXZSbJeJvtqkGgGUwjZ6HY2eo2mxWviLX5x_H_YFXc0J4GRei9KKO0LFOYgZhacG6ORcs1vDbWMBEmPEMVBBzPefjIAuKbtGN8kLrONahyINOnrHX5MAurDkilEUCvMEQGdHARJuuNgzXQ3WkleFZJ2mRToMEuaxaf0gXMgWxBBxJwSSTiCOJOEI-z7BFjgAxUt2CgpbXVwGGr5hJCz5Yixw3MJJqNZdTNd1KaJGTHWBtnwdjZFECgk8bpEmY_7ipo6yBPyO7WCocBfzvV0SCQ9SKMt5UyNxKrzHfImIHs78vwN7ju2cAia4HeY284_--85Q8HozTkRwNLz6_JU9cR1yX2veOHJTf1uY9-HqlPnEz-xc25k-1 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9owELbWTqv6sh_dj9JtrR_2mgCxEyePCIbKViqkFqnai2UnzkADg0qYxP6e_aG7c5IB1fbS12AuTvLl8118dx8hn-IE1gRmQi_NTeTxgCtseZt4iWYqizQs2BoLhYfX0eWYf7kL73akvlzSfqqnvp3NfTuduNzK5Txt1nlizdGwC2EMTzhrLrO8eUCewjsbJHWgXm0gcM4rEobzhpGoUruAjZuDzsAXzGc-hC4QQYVCuE8rTqBHMBSM3FujDnK12OkejMmTagX3Ly-FL_7lmT5MsNxZsfovyLf6WstElR_-utB--utBG8hH3YyX5Hnlx9JOOeQVeWLsCXlWKltuTsjRsNqzf01-d-gVUCpVNqMDi3UUP8G_zWh3AmDcADwpTB4lW7DOgg4X65WhI2vWc2QbOHLjVCwoaowAp1FwWOkQu5E6SNFFTnvGZk6wgXbNbLaitxNVwMTAysTYRbFZIg5nm3ICWA5T8z0c6yHF2bR4Q8b9z7fdS6_ShvBSLkThRS2hY53EDMLTnLUzLlis4dGxgIkw5SlQEXO95-MgDfJ23o6yXOs41qHIglaWsrfk0C6sOSWURQK8whCV0WCpNm1tGH4X1ZFWhqetpEFaNRrksmwBIl3oFMQSsCQFk0wiliRiCXU9wwY5BdRI9R2IWo5vAgxjMaMWfLEGOauhJNVqLqdqurXQIOd74NqeD-bIogQMX9Rok8ADuLmjrIEnI9tYMhwF_P8jIsEhekUb70p0bq1XuG8QsYfbvwOwB_n-L4BG14u8Qt_Zo_95QY5Gvb68Glx_fU-OXWNcl-H3gRwW92vzEVy-Qp-7l_sPsnhSNQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Live+and+Inactivated+Chlamydia+trachomatis+Mouse+Pneumonitis+Strain+Induces+the+Maturation+of+Dendritic+Cells+That+Are+Phenotypically+and+Immunologically+Distinct&rft.jtitle=Infection+and+immunity&rft.au=Rey-Ladino%2C+Jose&rft.au=Koochesfahani%2C+Kasra+M.&rft.au=Zaharik%2C+Michelle+L.&rft.au=Shen%2C+Caixia&rft.date=2005-03-01&rft.issn=0019-9567&rft.eissn=1098-5522&rft.volume=73&rft.issue=3&rft.spage=1568&rft.epage=1577&rft_id=info:doi/10.1128%2FIAI.73.3.1568-1577.2005&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_IAI_73_3_1568_1577_2005 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0019-9567&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0019-9567&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0019-9567&client=summon |